The stock is in a powerful, sustained long-term uptrend, evidenced by its 60.88% gain over the past year, significantly outperforming the broader market's 22.2% return. With a current price of $33.56, it is trading at approximately 74% of its 52-week range ($17.91 to $37.91), indicating it has retreated meaningfully from recent highs but remains solidly in the upper half of its annual band, suggesting the long-term bullish structure is intact but facing near-term consolidation. Recent momentum shows a divergence, with a strong 3.04% gain over the past month contrasting with a more modest 0.75% gain over three months, indicating a potential reacceleration of bullish momentum after a period of sideways action; this is further supported by a 1-month relative strength of +7.32% versus the SPY. Key technical support is anchored at the 52-week low of $17.91, though more immediate support lies near the recent March low around $31.67, while resistance is clearly defined at the 52-week high of $37.91; a decisive breakout above $38 would signal a resumption of the primary uptrend, whereas a break below $31.67 could indicate a deeper correction. The stock's beta of 0.618 indicates it has been approximately 38% less volatile than the market, which is notable for a mid-cap name and suggests it has exhibited defensive characteristics during its advance.

Revenue trajectory analysis is constrained as specific quarterly revenue and growth rate figures are not available in the provided data; however, the analyst consensus points to an estimated annual revenue of approximately $2.23 billion, and recent news references a $1.7 billion revenue outlook, suggesting the market is focused on steady top-line execution. The company is profitable, with a trailing EPS of $0.057 and a robust net margin of 16.55%, while its gross margin stands at 28.33% and operating margin at 25.33%; these healthy profitability metrics indicate efficient operations relative to its capital-intensive industry. Balance sheet health appears mixed, with a strong Return on Equity of 23.71% signaling effective use of shareholder capital, but a current ratio of 0.60 points to potential short-term liquidity constraints, which is mitigated by a manageable debt-to-equity ratio of 0.71, indicating a balanced use of leverage without excessive financial risk.